Nuveen Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,809
| Closed | -$310K | – | 3484 |
|
|
2022
Q1 | $310K | Buy |
4,809
+80
| +2% | +$5.16K | ﹤0.01% | 3119 |
|
|
2021
Q4 | $685K | Sell |
4,729
-348
| -7% | -$50.4K | ﹤0.01% | 2981 |
|
|
2021
Q3 | $847K | Sell |
5,077
-343
| -6% | -$57.2K | ﹤0.01% | 3048 |
|
|
2021
Q2 | $1.49M | Buy |
5,420
+2,095
| +63% | +$576K | ﹤0.01% | 2842 |
|
|
2021
Q1 | $712K | Buy |
3,325
+542
| +19% | +$116K | ﹤0.01% | 3002 |
|
|
2020
Q4 | $672K | Buy |
2,783
+279
| +11% | +$67.4K | ﹤0.01% | 2943 |
|
|
2020
Q3 | $264K | Buy |
2,504
+876
| +54% | +$92.4K | ﹤0.01% | 3108 |
|
|
2020
Q2 | $160K | Sell |
1,628
-210
| -11% | -$20.6K | ﹤0.01% | 3126 |
|
|
2020
Q1 | $138K | Buy |
1,838
+118
| +7% | +$8.86K | ﹤0.01% | 3036 |
|
|
2019
Q4 | $140K | Hold |
1,720
| – | – | ﹤0.01% | 3102 |
|
|
2019
Q3 | $210K | Sell |
1,720
-125
| -7% | -$15.3K | ﹤0.01% | 3116 |
|
|
2019
Q2 | $331K | Buy |
+1,845
| New | +$331K | ﹤0.01% | 3089 |
|